Neural Development
Neural development describes the growth and development of the nervous system starting from embryogenesis and continuing throughout life.
Neural Development Products Targets
- FGFR (5)
- GABAB Receptor (28)
- Others (13)
- Stem Cell Signaling (27)
- Stem Cell Proliferation (25)
- Reprogramming (17)
- Nucleoside Transporter (5)
- Glycine Transporter (6)
- GABA (10)
- Cannabinoid Transporter (10)
- Acetylcholine Transporter (1)
- D4 Receptor (12)
- PORCN (4)
- beta-catenin (13)
- Casein Kinase 1 (7)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- D3 Receptor (12)
- Vesicular Monoamine Transporter (4)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Glutamate Transporter (18)
- Dopamine Transporter (20)
- Tankyrase (5)
- Adrenergic Transporter (23)
- 5-HT Transporter (30)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Stem Cell Differentiation (54)
- Delta opioid receptor (16)
- Adrenergic α2 Receptor (33)
- Adrenergic α1 Receptor (22)
- Adrenergic β3 Receptor (12)
- Adrenergic β2 Receptor (6)
- Adrenergic β1 Receptor (7)
- Hedgehog Signaling (15)
- Cancer Stem Cell (9)
Products for Neural Development - Page 7
- Cat.No. Product Name Information/Activity
-
BCC6599
(RS)-(Tetrazol-5-yl)glycine
(RS)-(Tetrazol-5-yl)glycine (D,L-(tetrazol-5-yl)glycine) is a highly potent and selective N-methyl-D-aspartate (NMDA) receptor agonist. (RS)-(Tetrazol-5-yl)glycine has EC50s of 99 nM, 1.7 μM for GluN1/GluN2D and GluN1/GluN2A, respectively. (RS)-(Tetrazol-5-yl)glycine induces seizure responses and Fos in mice.
-
BCC6584
ACBC
22264-50-2
-
BCC7753
DL-AP5 Sodium salt
1303993-72-7
-
BCC6553
D-AP5
D-AP5 is a NMDA receptor antagonist.
-
BCC6552
DL-AP5
76326-31-3
-
BCC6554
L-AP5
79055-67-7
-
BCC6551
DL-AP7
78966-69-5
-
BCC6631
Arcaine sulfate
14923-17-2
-
BCC6602
(R)-4-Carboxyphenylglycine
134052-68-9
-
BCC7078
CGP 37849
CGP 37849 is a potent, competitive and orally active N-methyl-D-aspartate (NMDA) receptor antagonist. CGP 37849 is an anticonvulsant in rodents and has antidepressant and anxiolytic-like effects.
